Holen Sie sich die Stockscreener-App
4.14
7.81%
0.30
Handel nachbörslich:
4.19
0.05
+1.21%
Schlusskurs vom Vortag:
$3.84
Offen:
$3.84
24-Stunden-Volumen:
10.00M
Relative Volume:
1.80
Marktkapitalisierung:
$1.52B
Einnahmen:
$4.09M
Nettoeinkommen (Verlust:
$-660.15M
KGV:
-1.7959
EPS:
-2.3053
Netto-Cashflow:
$-117.10M
1W Leistung:
+6.43%
1M Leistung:
+3.11%
6M Leistung:
-2.13%
1J Leistung:
+84.82%
1-Tages-Spanne:
$3.83
$4.34
1-Wochen-Bereich:
$3.6701
$4.34
52-Wochen-Spanne:
$2.00
$6.75
Ataibeckley Inc Stock (ATAI) Company Profile
Firmenname
Ataibeckley Inc
Sektor
Branche
Telefon
1 929 207 2670
Adresse
C/O ATAI LIFE SCIENCES US, INC., NEW YORK
Compare ATAI vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATAI
Ataibeckley Inc
|
4.14 | 1.41B | 4.09M | -660.15M | -117.10M | -2.3053 |
VRTX
Vertex Pharmaceuticals Inc
|
453.17 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
614.73 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
878.49 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
281.90 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
156.58 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Ataibeckley Inc Stock (ATAI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-27 | Eingeleitet | Deutsche Bank | Buy |
| 2026-01-20 | Eingeleitet | Guggenheim | Buy |
| 2025-10-13 | Eingeleitet | Needham | Buy |
| 2025-07-29 | Eingeleitet | Oppenheimer | Outperform |
| 2024-11-18 | Bestätigt | H.C. Wainwright | Buy |
| 2024-04-03 | Hochstufung | Maxim Group | Hold → Buy |
| 2022-11-01 | Eingeleitet | Loop Capital | Buy |
| 2021-11-30 | Eingeleitet | Maxim Group | Buy |
| 2021-11-11 | Eingeleitet | ROTH Capital | Buy |
| 2021-10-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-09-01 | Eingeleitet | Jefferies | Buy |
| 2021-07-13 | Eingeleitet | Berenberg | Buy |
| 2021-07-13 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-07-13 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2021-07-13 | Eingeleitet | Citigroup | Buy |
| 2021-07-13 | Eingeleitet | Cowen | Outperform |
| 2021-07-13 | Eingeleitet | Credit Suisse | Outperform |
| 2021-07-13 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-07-08 | Eingeleitet | Aegis Capital | Buy |
Alle ansehen
Ataibeckley Inc Aktie (ATAI) Neueste Nachrichten
ATAI: Advancing late-stage psychedelics for depression with key data readouts and strong financial runway - TradingView
ATAI: Advancing late-stage psychedelics for mental health, with key phase III and II-B trials underway - TradingView
Is AtaiBeckley Inc. (ATAI) the Hidden Penny Stock to Invest In? - Yahoo Finance
ATAI Stock Quote Price and Forecast - CNN
AtaiBeckley Inc. (ATAI) Holds Above Key Support, Posts Modest GainTrend Continuation Trade - newsline.com
ATAIBECKLEY INC. Files Form 8-K with SEC: Company Details, Stock Information, and NASDAQ Listing - Minichart
H.C. Wainwright reiterates Buy on Atai stock, $25 target By Investing.com - Investing.com Australia
AtaiBeckley Inc. (ATAI) awards 121,968 stock options to director - Stock Titan
AtaiBeckley Inc. (ATAI) director granted 121,968 stock options at $4.50 - Stock Titan
AtaiBeckley (ATAI) grants director 121,968 stock options at $4.50 - Stock Titan
AtaiBeckley (NASDAQ: ATAI) shareholders back board slate and Deloitte as 2026 auditor - Stock Titan
H.C. Wainwright reiterates Buy on Atai stock, $25 target - Investing.com UK
Director Christian Angermayer awarded 121,968 ATAI stock options at $4.50 - Stock Titan
Atai Beckley N.V. (ATAI) A Top Penny Stock to Buy Poised to Build Sustained Clinical and Shareholder Value - Yahoo Finance
ATAI Q1 2026 Earnings: Narrower Loss Beats Estimates, Stock Declines Amid Market VolatilityEarnings Quality Score - newsline.com
AtaiBeckley (ATAI) Among the Best Penny Stocks with Huge Upside Potential - Insider Monkey
AtaiBeckley (ATAI) Drops Over 12%: Testing Key Support at $3.75Value Stock Ideas - newsline.com
5 Best Penny Stocks with Huge Upside Potential - Insider Monkey
Small cap wrap: Gunnison Copper, Trillion Energy, AtaiBeckley… - Proactive financial news
AtaiBeckley nears key clinical catalysts, Jefferies stays positive with repeat ‘Buy’ rating - Yahoo! Finance Canada
Is AtaiBeckley’s BPL-003 Phase 3 Launch Altering The Investment Case For AtaiBeckley (ATAI)? - Yahoo Finance
Jefferies reiterates atai Life Sciences stock rating on pipeline progress - Investing.com
Assessing AtaiBeckley (ATAI) Valuation After Strong Returns And Elevated Price To Book Ratio - Yahoo Finance
Is AtaiBeckley (ATAI) Using BPL-003’s Phase 3 Launch to Redefine Its Risk‑Reward Profile? - simplywall.st
ATAI: BPL-003 enters phase III for depression, with top-line data expected in early 2029 - TradingView
ATAI: BPL-003 phase III for depression begins, with VLS-01 phase IIb results due Q4 2024 - TradingView
AtaiBeckley to discuss Phase 3 BPL-003 program at multiple June investor conferences - TradingView
AtaiBeckley (NASDAQ: ATAI) to present BPL-003 Phase 3 updates - Stock Titan
ATAI Q1 2026 Earnings: Narrower Than Expected Loss Drives Positive Surprise Despite Modest Stock Decline - newsline.com
AtaiBeckley Grant Program Links Mental Health Impact With Investor Considerations - Sahm
ATAI Q1 2026 Earnings: Narrower Loss Beats Estimates; Stock Edges HigherEarnings Weakness Phase - thelegaladvocate.com
AtaiBeckley Launches Patient Impact Grant Program for Mental Health Non-Profit Organizations - Investing News Network
Small cap wrap: AtaiBeckley, Medicus Pharma, Bit Digital, American Resources, Nextech3D.ai… - Proactive financial news
AtaiBeckley launches mental health patient impact grant program - Proactive financial news
New $20,000 mental health grants for nonprofits now open for applications - Stock Titan
AtaiBeckley to present at multiple investor conferences in June 2026, highlighting its mental health drug pipeline. - Pluang
AtaiBeckley to Participate in Upcoming Investor Conferences in June 2026 - Investing News Network
AtaiBeckley to participate in multiple June investor conferences - Proactive financial news
AtaiBeckley Inc. Cash Flow – HAM:B72 - TradingView
Total debt of AtaiBeckley Inc. – HAM:B72 - TradingView
AtaiBeckley Inc. Balance Sheet – HAM:B72 - TradingView
Return on assets % of AtaiBeckley Inc. – HAM:B72 - TradingView
AtaiBeckley Inc. Trade Ideas — HAM:B72 - TradingView
ATAI Q1 2026 Earnings: Narrower-Than-Expected Loss Fails to Lift SharesInterim Report - newsline.com
ATAI Q1 2026 Earnings: Narrower-than-Expected Loss as Clinical Pipeline AdvancesRevenue Beat Analysis - newsline.com
AtaiBeckley (ATAI) Reports Q1 Financial Results - Insider Monkey
AtaiBeckley Inc. (ATAI) Surges 5.87%: Testing Key Resistance LevelsDip Buy Trade - The Legal Advocate
10 Best Penny Stocks to Buy for Long Term - Insider Monkey
These stocks are today’s movers: Fermi, AST SpaceMobile, Intel, Marvell, USA Rare Earth, Ataibeckley, and more - MSN
AtaiBeckley Inc. (NASDAQ: ATAI): Advancing Psychedelic Mental Health Therapies with Clinical Momentum - Kalkine
How AtaiBeckley’s Wider Q1 Loss But Lower Per-Share Hit At AtaiBeckley (ATAI) Has Changed Its Investment Story - simplywall.st
Finanzdaten der Ataibeckley Inc-Aktie (ATAI)
Umsatz
Nettogewinn
Free Cashflow
ENV
Ataibeckley Inc-Aktie (ATAI) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Craig Kevin James | Chief Medical Officer |
Apr 20 '26 |
Sale |
5.00 |
42,579 |
212,895 |
8,437 |
1.27%
1.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):